Back
Xerox Holdings 10K Form
Sell
28
XRX
Xerox Holdings
Last Price:
8.41
Seasonality Move:
9.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | XRX/Xerox Holdings Quarterly |
2024-02-23 | 10K | XRX/Xerox Holdings Annual |
2023-10-30 | 10Q | XRX/Xerox Holdings Quarterly |
2023-08-02 | 10Q | XRX/Xerox Holdings Quarterly |
2023-05-01 | 10Q | XRX/Xerox Holdings Quarterly |
2023-02-23 | 10K | XRX/Xerox Holdings Annual |
Receive XRX News And Ratings
See the #1 stock for the next 7 days that we like better than XRX
XRX Financial Statistics
Sales & Book Value
Annual Sales: | $6.89B |
---|---|
Cash Flow: | $107M |
Price / Cash Flow: | 2.02 |
Annual Sales: | $10.48 |
Price / Book: | 0.79 |
Profitability
EPS (TTM): | -11.04000 |
---|---|
Net Income (TTM): | $-1.36B |
Gross Margin: | $2.31B |
Return on Equity: | -57.17% |
Return on Assets: | -14.09% |
Xerox Holdings Earnings Forecast
Key Xerox Holdings Financial Ratios
- The Gross Profit Margin over the past 40 years for XRX is 33.60%.
- The Selling, General & Administrative Expenses for XRX have been equal to 24.63% of Gross Profit Margin.
- The Research & Development expenses have been 3.33% of Revenue.
- The Interest Expense is 6,800.00% of Operating Income.
- The Net Earning history of XRX is 0.01% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 22 years.
Xerox Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Technology Hardware, Storage & Peripherals |
Sector: | Information Technology |
Current Symbol: | XRX |
CUSIP: | 984121 |
Website: | xerox.com |
Debt
Debt-to-Equity Ratio: | 2.51 |
---|---|
Current Ratio: | 1.26 |
Quick Ratio: | 0.86 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 5.58 |
XRX Technical Analysis vs Fundamental Analysis
Sell
28
Xerox Holdings (XRX)
is a Sell
Is Xerox Holdings a Buy or a Sell?
-
Xerox Holdings stock is rated a Sell
The current Xerox Holdings [XRX] share price is $8.29. The Score for XRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.